NCT05208164 My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
| NCT ID | NCT05208164 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-04-01 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2021-04-01 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed research and training will allow Dr. Alana Biggers to obtain critical research skills and study a mindfulness meditation program designed to improve sleep and reduce stress in African-American adults with diabetes. If effective, this program may reduce the risk of cardiovascular disease among African-Americans with type 2 diabetes who are at high risk of cardiovascular disease.
Eligibility Criteria
Inclusion Criteria * Self-identifies as African American or Black * Diagnosis of type 2 diabetes * Valid address in greater Chicagoland area * Mobile phone with unlimited text-messaging * Mobile device (smartphone, tablet, or computer) with the ability to connect to the internet if remote online delivery * Availability to participate in mindfulness class either in-person or online * Age 21-75 Exclusion Criteria * Untreated obstructive sleep apnea (OSA) * Severe insomnia, narcolepsy, or REM sleep related disorder * Major cognitive impairments or psychiatric disorder * Alcohol or drug abuse * Limited English proficiency * Inability to send/receive text messages * Currently engaging in mindfulness practice
Contact & Investigator
Alana Biggers
PRINCIPAL INVESTIGATOR
University of Illinois at Chicago
Frequently Asked Questions
Who can join the NCT05208164 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 75 Years, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05208164 currently recruiting?
Yes, NCT05208164 is actively recruiting participants. Contact the research team at abigger2@uic.edu for enrollment information.
Where is the NCT05208164 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05208164 clinical trial?
NCT05208164 is sponsored by University of Illinois at Chicago. The principal investigator is Alana Biggers at University of Illinois at Chicago. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.